Access Evidence Lead - 12 months contract

Roche • South San Francisco, CA

11d • Hybrid

About The Position

At Roche, we are passionate about transforming patients’ lives. We are brave in both decision and action and believe that good business means a better world. That is why we come to work each day. We commit ourselves to scientific rigor, unassailable ethics, and access to medical innovations for all. We do this today to build a better tomorrow. The Global Access (GA) organization is a key part of this mission. We are seeking a dedicated Access Evidence Lead to join our RWE and Post-Launch pod, a specialized team focused on ensuring our medicines remain accessible to patients throughout their entire lifecycle. This is a unique opportunity to shape and sustain the value of our in-market medicines through evidence as an individual contributor in a dual-responsibility role.

Requirements

• Master's or doctoral-level degree (MSc, PhD, PharmD) in a quantitative discipline such as Health Economics, Epidemiology, Statistics, or Public Health.
• At least 5 years of relevant experience in the pharmaceutical industry, a health technology assessment agency, or a HEOR consultancy.
• Demonstrated experience in designing and implementing RWE studies for market access, developing/adapting health economic models (CEMs, BIMs), conducting SLRs/ITCs, and supporting HTA submissions while responding to questions from HTA bodies.
• Strong analytical skills, proficiency with relevant software (e.g., R for statistical analysis; MS Excel including VBA for economic modeling), and are an excellent communicator and collaborator.
• A proactive, solution-oriented professional driven by scientific innovation and passionate about demonstrating product value through evidence to make a meaningful impact for patients through teamwork.

Responsibilities

• Identify critical launch and post-launch evidence gaps, design robust RWE studies to fill them, and collaborate closely with global and affiliate colleagues on study design, execution, and dissemination of results.
• Take ownership of and update core global HTA deliverables—including cost-effectiveness models (CEMs), budget impact models (BIMs), systematic literature reviews (SLRs), indirect treatment comparisons (ITCs), and Global Value Dossiers (GVDs)—for established medicines (2-3 years after launch).
• Act as the primary technical partner for affiliates in later-launching countries or those facing access re-negotiations, providing hands-on support to update HTA deliverables to meet specific needs and assisting with answering technical questions from HTA bodies and payers.
• Work seamlessly with colleagues across Global Access, Medical Affairs, Commercial, Product Development Data, Real-World Data, and affiliates to deliver integrated evidence solutions in a highly collaborative, global matrix environment.
• Serve as a strategic expert and subject-matter expert on the application of RWE for market access and on updating HTA deliverables for lifecycle management to ensure continued patient access.

What This Job Offers

• Job Type: Full-time
• Career Level: Mid Level